newsfilter
← Latest News
GlobeNewswire·

AVEO Oncology Announces Participation at the H.C. Wainwright Virtual BioConnect 2022 Conference

BOSTON, Dec. 22, 2021 (GLOBE NEWSWIRE) -- AVEO Oncology (NASDAQ:AVEO), a commercial stage, oncology-focused biopharmaceutical company, today announced that members of its senior management team will participate in the H.C. Wainwright Virtual BioConnect